These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 17905674)
1. Src family kinases: regulation of their activities, levels and identification of new pathways. Ingley E Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674 [TBL] [Abstract][Full Text] [Related]
2. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1. Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282 [TBL] [Abstract][Full Text] [Related]
4. Csk-binding protein can regulate Lyn signals controlling cell morphology. Ingley E Int J Biochem Cell Biol; 2009 Jun; 41(6):1332-43. PubMed ID: 19124084 [TBL] [Abstract][Full Text] [Related]
5. Yeast two-hybrid in vivo association of the Src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of PI 3-kinase. Dombrosky-Ferlan PM; Corey SJ Oncogene; 1997 May; 14(17):2019-24. PubMed ID: 9160881 [TBL] [Abstract][Full Text] [Related]
6. Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. Rathore VB; Okada M; Newman PJ; Newman DK Biochem J; 2007 Apr; 403(2):275-81. PubMed ID: 17233630 [TBL] [Abstract][Full Text] [Related]
7. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity. Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137 [TBL] [Abstract][Full Text] [Related]
8. Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts. Shima T; Nada S; Okada M Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14897-902. PubMed ID: 14645715 [TBL] [Abstract][Full Text] [Related]
9. Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Tauzin S; Ding H; Khatib K; Ahmad I; Burdevet D; van Echten-Deckert G; Lindquist JA; Schraven B; Din NU; Borisch B; Hoessli DC Blood; 2008 Feb; 111(4):2310-20. PubMed ID: 18070987 [TBL] [Abstract][Full Text] [Related]
10. Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomains. Tanaka H; Akagi K; Oneyama C; Tanaka M; Sasaki Y; Kanou T; Lee YH; Yokogawa D; Dobenecker MW; Nakagawa A; Okada M; Ikegami T J Biol Chem; 2013 May; 288(21):15240-54. PubMed ID: 23548896 [TBL] [Abstract][Full Text] [Related]
11. Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation. Wong L; Lieser SA; Miyashita O; Miller M; Tasken K; Onuchic JN; Adams JA; Woods VL; Jennings PA J Mol Biol; 2005 Aug; 351(1):131-43. PubMed ID: 16002086 [TBL] [Abstract][Full Text] [Related]
12. Regulation of FynT function by dual domain docking on PAG/Cbp. Solheim SA; Torgersen KM; Taskén K; Berge T J Biol Chem; 2008 Feb; 283(5):2773-83. PubMed ID: 18056706 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of Csk-mediated down-regulation of Src family tyrosine kinases in epidermal growth factor signaling. Matsuoka H; Nada S; Okada M J Biol Chem; 2004 Feb; 279(7):5975-83. PubMed ID: 14613929 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis for regulation of Src by the docking protein p130Cas. Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368 [TBL] [Abstract][Full Text] [Related]
15. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis. Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538 [TBL] [Abstract][Full Text] [Related]
16. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases. Chong YP; Mulhern TD; Cheng HC Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715 [TBL] [Abstract][Full Text] [Related]
17. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. Trible RP; Emert-Sedlak L; Smithgall TE J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330 [TBL] [Abstract][Full Text] [Related]
19. Csk-binding protein controls red blood cell development via regulation of Lyn tyrosine kinase activity. Plani-Lam JH; Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Singer P; Lam KP; Hibbs ML; Ingley E Exp Hematol; 2017 Feb; 46():70-82.e10. PubMed ID: 27751872 [TBL] [Abstract][Full Text] [Related]
20. Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src. Place AT; Chen Z; Bakhshi FR; Liu G; O'Bryan JP; Minshall RD Mol Pharmacol; 2011 Oct; 80(4):665-72. PubMed ID: 21778303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]